Rini BI - Search Results

1

Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab.

Ornstein MC, George L, Wei W, Diaz-Montero CM, Rayman P, Martin A, Basu A, Beckermann KE, Nizam A, Wee CE, Gilligan TD, Gupta S, Rini BI. Ornstein MC, et al. Among authors: rini bi. Clin Genitourin Cancer. 2024 Dec;22(6):102181. doi: 10.1016/j.clgc.2024.102181. Epub 2024 Jul 31. Clin Genitourin Cancer. 2024. PMID: 39208489 Free article. Clinical Trial.

2

Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.

Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.

3

A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Small EJ. Rini BI, et al. Cancer. 2005 Feb 1;103(3):553-8. doi: 10.1002/cncr.20795. Cancer. 2005. PMID: 15612026 Free article. Clinical Trial.

4

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Dunlap S, Elchinoff A, Yu N, Bok R, Simko J, Small EJ. Rini BI, et al. Cancer. 2006 Feb 1;106(3):566-75. doi: 10.1002/cncr.21661. Cancer. 2006. PMID: 16369983 Free article. Clinical Trial.

5

SU11248 and AG013736: current data and future trials in renal cell carcinoma.

Rini BI. Rini BI. Clin Genitourin Cancer. 2005 Dec;4(3):175-80. doi: 10.3816/CGC.2005.n.029. Clin Genitourin Cancer. 2005. PMID: 16425985 Review.

6

Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports.

Shaheen PE, Rini BI, Bukowski RM. Shaheen PE, et al. Among authors: rini bi. Clin Genitourin Cancer. 2006 Jun;5(1):78-81. doi: 10.3816/CGC.2006.n.021. Clin Genitourin Cancer. 2006. PMID: 16859583

7

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: rini bi. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

8

Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.

Rini BI, Shaw V, Rosenberg JE, Kim ST, Chen I. Rini BI, et al. Clin Genitourin Cancer. 2006 Dec;5(3):232-4. doi: 10.3816/CGC.2006.n.042. Clin Genitourin Cancer. 2006. PMID: 17239278

9

Therapeutic considerations in patients with metastatic renal cell carcinoma previously treated with antiangiogenic therapies.

George S, Rini BI. George S, et al. Among authors: rini bi. Clin Genitourin Cancer. 2006 Dec;5 Suppl 1:S40-4. doi: 10.3816/cgc.2006.s.006. Clin Genitourin Cancer. 2006. PMID: 17239283 Review.

10

What is standard initial systemic therapy in metastatic renal cell carcinoma?

Rini BI, McDermott D, Atkins M. Rini BI, et al. Clin Genitourin Cancer. 2007 Mar;5(4):256-63. doi: 10.3816/cgc.2007.n.001. Clin Genitourin Cancer. 2007. PMID: 17553205 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters